Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Enzalutamide","url":"https:\/\/www.ortaakarsu.net\/?page_id=12351","facts":[{"label":"Active ingredient \/ generic name","value":"enzalutamide"},{"label":"ATC code","value":"L02BB04"},{"label":"Administration route","value":"Oral"}]},{"title":"Rimegepant","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=rimegepant","facts":[{"label":"Active ingredient \/ generic name","value":"rimegepant"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed SPL version 32; effective 2026-06-04; retrieved 2026-11-04"}],"sources":[{"label":"NURTEC ODT (rimegepant) \u2014 US prescribing information, DailyMed","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=9ef08e09-1098-35cc-e053-2a95a90a3e1d"},{"label":"FDA: clinical examples of drugs interacting with CYP enzymes and transporter systems","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:35490","available":true}}